SI
Sofinnova Investments Portfolio holdings
AUM
$1.47B
This Quarter Return
+2.5%
1 Year Return
+17.43%
3 Year Return
+337.79%
5 Year Return
+424.38%
10 Year Return
–
AUM
$1.28B
AUM Growth
-$181M
(-12%)
Cap. Flow
-$120M
Cap. Flow
% of AUM
-9.41%
Top 10 Holdings %
Top 10 Hldgs %
66.69%
Holding
88
New
13
Increased
13
Reduced
24
Closed
17
Top Buys
| 1 |
INZY
Inozyme Pharma
INZY
|
$53.3M |
| 2 |
CMPI
Checkmate Pharmaceuticals, Inc. Common Stock
CMPI
|
$41.5M |
| 3 |
Amgen
AMGN
|
$28.4M |
| 4 |
NCNA
NuCana
NCNA
|
$17.2M |
| 5 |
BioMarin Pharmaceuticals
BMRN
|
$14.9M |
Top Sells
| 1 |
PRNB
Principia Biopharma Inc. Common Stock
PRNB
|
$84.7M |
| 2 |
Gilead Sciences
GILD
|
$31M |
| 3 |
Coherus Oncology, Inc. Common Stock
CHRS
|
$27.5M |
| 4 |
Merck
MRK
|
$21.6M |
| 5 |
XLRN
Acceleron Pharma Inc.
XLRN
|
$17.8M |
Sector Composition
| 1 | Healthcare | 98.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Invesco QQQ Trust
QQQ
$365B
| – | – |
0
| – | – |
|
77
Rigel Pharmaceuticals
RIGL
$708M
| – | – |
-33,970
| Closed | -$622K |
|
78
Syndax Pharmaceuticals
SNDX
$1.39B
| – | – |
-91,964
| Closed | -$1.36M |
|
79
VYNE Therapeutics
VYNE
$8M
| – | – |
-10,077
| Closed | -$1.26M |
|
80
Health Care Select Sector SPDR Fund
XLV
$33.8B
| – | – |
0
| – | – |
|
81
SPDR NYSE Technology ETF
XNTK
$1.23B
| – | – |
0
| – | – |
|
|
MRNS
82
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| – | – |
0
| – | – |
|
|
MRTX
83
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| – | – |
-8,072
| Closed | -$922K |
|
|
CNST
84
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
| – | – |
-207,087
| Closed | -$6.22M |
|
|
PRNB
85
DELISTED
Principia Biopharma Inc. Common Stock
PRNB
| – | – |
-1,417,258
| Closed | -$84.7M |
|
|
HZNP
86
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| – | – |
-252,958
| Closed | -$14.1M |
|